Eu dossiers.xls
EU Dossiers with Product Supply tie-up
50+125, 100+125 mg orally disinetragting granules
75, 100 mg enteric coated tabs; 500 mg effervescent tabs
Acetylsalicylic Acid+Paracetamol+Caffeine
10 Acetylsalicylic Acid+Paracetamol+Codeine
500+250 mg orally disintegrating granules
250mg/10ml concentrate for solution for inf.
125, 250, 500 mg/2ml solution for injection
125mg/ 5 ml, 250mg/ 5 ml suspension, powder
500+100, 1000+200, 2000+200 mg sterlie injection in vials
250, 500, 1000, 2000 mg Injection, powder (vial + diluent ampoule)
250+125, 500+250, 1000+500, 2000+1000 mg Injection, powder (vial + diluent)
40+0.005, 40+0.01 mg/ml solution for injection in 1.8 ml vials
7.5 mg/ml concentrate for infusion in vials
200+6, 400+12 µg dry powder inhaler (caps + device)
Note: Products only offered for countries where 3rd party intellectual property rights are not infringed. However the ultimate responsibility lies exclusively
with the licensee.
EU Dossiers with Product Supply tie-up
50, 350 mg powder & solvent for solution for injection
600mg+400 IU, 1200+800 IU effervescent tabs
500mg+440 IU, 1000+880 IU effervescent granules
600mg+400 IU, 500+440 IU, 1000mg+880 IU chewable tabs
500mg+200 IU+65µg orally disintegrating granules
50mg/5ml, 150mg/15ml, 450mg/45ml Injection, solution
250, 500, 1000 mg powder for inj. (vial + diluent)
1000mg (IM, IV) 2000mg (only IV) powder & solvent for solution for injection
500, 1000, 2000 mg Injection, powder (vial + diluent amp)
500, 1000 mg IM; IV powder & solvent for solution for injection
Sodium 100, 250, 500, 1000, 2000 mg Injection, powder (vial + diluent amp)
500, 1000, 2000 mg powder & solvent for solution for injection
250, 500, 750, 1000, 1500, 2000 mg Injection, powder (vial + diluent)
250, 750, 1500 mg powder & solvent for solution for inj./inf.
alcoholic 70% v/v cutaneous sol in 125ml, 250ml bottles
aqueous cutaneos sol 2% w/v 10ml, 60ml (bottles & amps blow-fill-seal)
2mg/ml solution for injection in bottles of 100, 200 ml
2mg/ml (5, 10 ml), 5mg/ml (30ml) solution for inj.
150mg/ml (1, 2, 4, 6 ml) solution for inj.
500, 1000 mg powder & solvent for solution for injection
1mg Injection, powder (amps + diluent amps)
151 Codeine+Noscapin+D, L, N-Methylephedrine
Note: Products only offered for countries where 3rd party intellectual property rights are not infringed. However the ultimate responsibility lies exclusively
with the licensee.
EU Dossiers with Product Supply tie-up
50mg/2ml solution for inj; concentrate for solution for inf.
25, 50, 100 mg e.c. tabs; 25, 50, 75 mg g.r. caps
25mg GR + 50mg SR caps; 25mg GR + 75mg SR caps
25mg/5ml, 50mg/10ml, 125mg/25ml injection, solution in vials
20/0.5, 80/2 mg/ml solution for injection
1.25mg/ml, 2.5mg/ml, 5mg/2ml glass amps.
20mg/10ml, 50mg/25ml, 50mg/50ml, 200mg/100ml sol. for inj.
0.5mg powder & solvent for solution for perfusion
20+90, 20+100, 30+125, 30+150 µg tabs; triphasic tabs
Triphasic 25+180, 25+215, 25+250, 35+180, 35+215, 35+250 µg tabs
100mg/50ml, 200mg/100ml injection solution
25, 50, 75, 100 µg/ hr transdermal patch
100/50, 200/100, 400/200 mg/ml solution for infusion
100mg/50ml, 200mg/100ml Injection, solution
0.1 mg/ml (5ml, 10ml) solution for inj.
Note: Products only offered for countries where 3rd party intellectual property rights are not infringed. However the ultimate responsibility lies exclusively
with the licensee.
EU Dossiers with Product Supply tie-up
50, 100, 125, 250, 500 µg dry powder inhaler (caps + device)
dry powder inhaler 12 µg (caps + device)
200, 1000, 2000 mg lyophilized powder for injection
200mg/5ml, 1000mg/5ml solution for injection
200+150 mg orally disintegrating granules
270 Heparin+Hydroxyethyl Salicylate+Menthol
271 Heparin+Hydroxyethyl Salicylate+Menthol
5000 IU+5000mg+500mg per 100g gel; 50000 IU+5000mg+500mg per 100g gel
50 mg SR caps; 100mg/ ml drops; 3.8g/ 100g gel
2mg/2ml, 6mg/6ml concentrate for infusion solution
5, 10 mg powder for solution for injection
5mg/5ml 10mg/10ml, 20mg/20ml Injection, solution
250+250, 500+500 mg powder & solvent for injection
40mg/2ml, 100mg/5ml solution for injection
100 mg/ 5ml solution for injection or concentrate for solution for infusion
31 mg effervescent tabs; 35 mg orally disintegrating granules
Note: Products only offered for countries where 3rd party intellectual property rights are not infringed. However the ultimate responsibility lies exclusively
with the licensee.
EU Dossiers with Product Supply tie-up
2, 5, 25, 50, 100, 200 mg dispersible tabs
100 mg/ml concentrate for solution for infusion
5mg/ml solution for infusion (vials & bags)
oral solution 25, 50, 100 µg/5ml, 100 ml bottles
powder for oral solution 6.86, 10, 10.70, 13.125, 13.72 gm sachet
355 Magnesium+Potassium+L-Carnitine+Grape seed extract
300mg+2mg+1µg orally disintegrating granules
15mg/1.5ml injection solution in ampoules
1%, 2%, 3% solution for injection (cartridges)
10mg/ml, 50mg/5ml glass vial (flip off cap)
20, 40, 250 mg Injection, powder (amp + diluent amp)
40, 125, 500, 1000, 2000 mg Injection, powder in vials
5mg/5ml, 15mg/3ml, 50mg/10ml solution for injection
Note: Products only offered for countries where 3rd party intellectual property rights are not infringed. However the ultimate responsibility lies exclusively
with the licensee.
EU Dossiers with Product Supply tie-up
1mg/5ml vials; 0.05mg/ml, 0.1mg/ml, 0.2mg/ml, 0.5mg/ml ampoules.
2.5, 5, 7.5, 10, 15, 20 mg oro disperible tabs
40mg powder and solvent for solution for infusion in vials
50mg/10ml, 100mg/20ml, 200mg/40ml Injection, solution
15, 30, 60, 90 mg/10ml injection solution
40 mg lyophlized powder for injection (glass vial)
10mg/ml i.v. solution for infusion (in glass vials)
500, 1000 mg tabs; 500, 1000 mg effervescent tabs
500+15 mg chewable tabs; 500+30 mg effervescent tabs
447 Paracetamol+Dextromethorphan+Phenylephrine
650+12.2, 1000+12.2 mg direct to mouth tabs
100mg/ 5ml Injection, solution (amps + diluent amps)
100mg/2ml, 250mg/5ml solution for inj.
2+0.25, 3+0.375, 4+0.5g powder & solvent for solution for injection
Note: Products only offered for countries where 3rd party intellectual property rights are not infringed. However the ultimate responsibility lies exclusively
with the licensee.
EU Dossiers with Product Supply tie-up
150, 300 mg tabs; 75, 150, 300 mg effervescent tabs
1mg/3ml, 2mg/5ml, 5mg/10ml concentrate for infusion
1, 2, 5 mg lyoph powder for solution for inj./inf.
2mg/ml, 5mg/ml, 7.5mg/ml, 10mg/ml ampoules & vials
50, 100 µg effervescent tabs; 50, 100 µg orally disintegrating granules
524 Sodium Alginate+Sodium Bicarbonate+Calcium Carbonate
0.25, 3, 6 mg powder & solvent for solution for infusion
200, 400 mg powder for infusion (glass vials)
20 mg Injection, powder (vial + diluent amp)
Note: Products only offered for countries where 3rd party intellectual property rights are not infringed. However the ultimate responsibility lies exclusively
with the licensee.
EU Dossiers with Product Supply tie-up
20 mg tabs; 40mg/ml solution for injection
50mg/2ml, 100mg/2ml solution for injection; 100mg/100ml infusion bottle
300mg/5ml solution for inhalation (ampoules blow-fill-seal)
500mg/5ml ampoules; 100mg/ml solution in vials
80+12.5, 160+12.5, 160+25, 320+12.5, 320+25 mg tabs
Bromide 4, 10, 20 mg inj. powd. in vials (amps + diluent amps)
10mg/1ml, 50mg/5ml solution for injection in vials
616 Zinc+Histidine+Vitamin C+Citrusflavonoids
10+50+300+5 mg orally disintegrating granules
617 Zinc+Vit C+Citrusflavonoids+herbal extracts
Note: Products only offered for countries where 3rd party intellectual property rights are not infringed. However the ultimate responsibility lies exclusively
with the licensee.
Source: http://www.targopharma.com/product_list.pdf
CASH COLLATERAL Rosenberg, Musso & Weiner, L.L.P., Brooklyn, New York § 363. Use, sale, or lease of property (a) In this section, “cash collateral” means cash, negotiable instruments, documents of title, securities, deposit accounts, or other cash equivalents whenever acquired in which the estate and an entity other than the estate have an interest and includes the proceeds
Programme de formation-recherche « La philosophie des sciences en Autriche et en France au XXème siècle: histoires croisées, héritages, réceptions et influences réciproques » Compte rendu du workshop des 23 et 24 novembre 2007 Les premières journées organisées les 23 et 24 novembre 2007 – dans le cadre du programme de formation-recherche « La philosophie des sciences en Aut
A |
B |
C |D |E |
F |
G |H |I |
J |
K |
L |
M |N |O |
P |
Q |
R |
S |
T |U |V |
W |
X |
Y |
Z |0-9 |